Cargando…
Dermato-neuro Syndrome after COVID-19 Vaccination in a Patient with Scleromyxoedema Previously Controlled with Bortezomib and Intravenous Immunoglobulins
Autores principales: | GALLO, Rosella, TRAVE, Ilaria, COTZIA, Emilia, RUSSO, Roberto, PARODI, Aurora |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Society for Publication of Acta Dermato-Venereologica
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9811295/ https://www.ncbi.nlm.nih.gov/pubmed/36511333 http://dx.doi.org/10.2340/actadv.v102.4430 |
Ejemplares similares
-
Massive Acute Alopecia of the Scalp in a Patient Treated with Dupilumab
por: GALLO, Rosella, et al.
Publicado: (2020) -
Long-term efficacy of high doses of intravenous immunoglobulins in generalized scleromyxoedema: Case report
por: Arginelli, Federica, et al.
Publicado: (2016) -
A Case of Scleromyxoedema with Thyroid Dysfunction
por: Li, Lin, et al.
Publicado: (2014) -
Monoclonal Gammopathy of Undetermined Significance-associated Scleromyxoedema
por: Baxi, Kalgi D., et al.
Publicado: (2019) -
Hail the Dermato-Trichologist!
por: Yesudian, Patrick
Publicado: (2014)